当前位置: 首页 > 期刊 > 《心脑血管病防治》 > 20196
编号:13524696
脑脊液和血浆中tau蛋白及神经颗粒素在急性颅脑损伤患者中检测的临床意义(3)
http://www.100md.com 2019年12月1日 《心脑血管病防治》 20196
     【9】Mattsson N,Zetterberg H,Janelidze S,et al. Plasma tau in Alzheimer dis-easd【J】. Neurology ,2016,87(17 ):1827-1835.

    【10】徐靜,王绪山,陆荣柱.急性颅脑损伤患者神经颗粒素测定的临床意义【J】.临床检验杂志,2016,34(11 ):843-845.

    【11】吕燕华,王海英,庄严,等.结核性与化脓性脑膜炎患者血浆及脑脊液生化指标检测结果对照研究【J】.中华医院感染学杂志,2017,27(7 ):1483-1486.

    【12】Dage JL,Wennberg AM,Airey DC,et al. Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a popu-lation-based elderly cohort【J】. Alzheimers Dement ,2016,12(12 ):1226-1234.

    【13】Bogoslovsky T,Wilson D,Chen Y,et al. Increases of plasma levels ofGlial Fibrillary acidic protein,tau,and Amyloid βup to 90 days after trau-matic brain injury【J】. J Neurotrauma,2016,34(1 ):66-73.

    【14】Kester MI,Teunissen CE,Crimmins DL,et al. Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer disease【J】. JAMA Neurol,2015,72(11 ):1275-1280.

    【15】attanzi S,Silvestrini M. Neurothrombectomy in the management of acuteischemic stroke【J】. Cerebrovascular Diseases,2015,40(3-4 ):198-199.

    (收稿日期:2019-3-24 ), http://www.100md.com(王航 宋歌 刘永建 谢万福)
上一页1 2 3